India FTA Calendar 2026: UK Oman New Zealand Trade Deals

India launches major FTA push with UK, Oman, New Zealand in 2026. Free trade deals unlock export growth, tariff cuts, and GDP expansion across pharma,

7
Impact
Score / 10
💡 Key Takeaway India's FTA push with UK, Oman, and New Zealand is a structural positive for export-driven growth, unlocking 10-15% incremental export revenue in pharma, textiles, and chemicals by 2027, while creating long-term jobs and supporting 6-7% GDP growth trajectory—but implementation risks and input cost inflation could dampen early enthusiasm.
🏭 Affected Industries
🏭 Industry Impact Details

Textiles & Apparel — UK and New Zealand FTAs provide zero-tariff market access for Indian textiles, apparel, and processed fabrics, significantly boosting export competitiveness.

Pharmaceuticals — FTAs reduce regulatory barriers and tariffs for Indian pharma exports to developed markets, increasing market share in generics and specialty drugs.

Agriculture & Food Processing — Oman FTA opens Gulf markets for Indian agricultural products, spices, and processed foods with preferential tariff treatment.

Automobile & Auto Components — FTAs with developed economies enhance Indian auto component exports through tariff elimination and simplified rules of origin.

Information Technology — Services liberalization under FTAs increases opportunities for Indian IT consulting, software, and BPO services in UK and New Zealand markets.

Chemicals & Petrochemicals — Oman agreement facilitates petrochemical trade and raw material sourcing, improving margins for Indian chemical manufacturers.

Shipping & Logistics — Increased bilateral trade volumes from FTAs drive logistics demand, benefiting Indian shipping companies and port operators.

Defence & Aerospace — UK FTA may unlock defence procurement opportunities and joint ventures, positioning India in advanced aerospace supply chains.

📈 Stock Market Impact
👥 Who is Affected & How?

Average Indians will benefit from cheaper imported goods and services, potential job creation in export-led sectors, but may face localized competition in some domestic industries. Real wages could improve through employment growth in pharma, textiles, and IT sectors, with some consumer prices moderating for imported goods.

• Job creation in export-focused industries (textiles, pharma, IT) offsets import-driven job losses in lower-skill sectors

• Modestly lower prices for imported consumer goods and electronics from UK and New Zealand in 12-18 months

• Wage growth in export sectors may partially offset inflation as companies expand capacity and hiring

FTAs represent a structural tailwind for export-oriented Indian companies, with 3-5 year earnings growth visibility in pharma, textiles, and auto components. Sectoral rotation toward exporting champions and logistics is justified, though valuations may already price in near-term benefits.

• Pharma and textiles offer 15-25% earnings CAGR through 2028 driven by incremental market access and volume growth

• Infrastructure and logistics plays (ports, shipping) offer 12-18% returns over 2-3 years as trade volumes scale

• Monitor rupee strength and input cost inflation as risks to margin expansion in export sectors

Near-term market catalysts include sector rotation into exporters and logistics on FTA announcement momentum, with likely volatility in pharma and textile stocks over next 2-4 weeks. Price discovery in frontline export stocks will occur as market re-rates earnings multiples upward.

• Buy pharma and textiles on any 3-5% dips; expect 8-12% upside over next 3 months on FTA euphoria and upgrades

• Logistics and port stocks (Adani Ports, SCI) likely to re-rate; watch for breakouts above 200-day moving averages

• Key event: FTA signing ceremonies and tariff schedule publication in Q1 2026; monitor for surprises in sensitive sectors